Journals / Ulusal Cerrahi Dergisi / 2016 / Cilt: 32 - Sayı: 4

Arseniğin sebep olduğu karaciğer hasarında melatoninin karaciğer foksiyonları üzerine etkileri

The effects of melatonin on liver functions in arsenic-induced liver damage

Pages
233–237
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Albumin, interleukin-6 (IL-6), total protein, alanine transaminase, aspartate transaminase, macrophage migration inhibitory factor, and monocyte chemotactic protein-1 measurements were obtained.Results: In rats with liver damage due to arsenic exposure, melatonin administration significantly decreased the levels of IL-6, macrophage migration inhibitory factor, and monocyte chemotactic protein-1 (p<0.001, p=0.02 and p=0.04, respectively).Conclusion: After evaluating liver enzymes and inflammatory markers, this study determined that melatonin exposure improves liver tissue damage caused by arsenic exposure, with the degree of improvement varying based on the levels of arsenic exposure.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Arsenic exposure is increasing in communities due to environmental pollution and industrial development.
📊
Key Findings & Data:In this study, we aimed to evaluate melatonin's protective effects on livers damaged by arsenic toxicity.Materials and Methods: Twenty-four Sprague-Dawley male rats were classified into three groups: a control group, an arsenic applied group, and an arsenic plus 10 mg/kg melatonin applied group.
💡
Conclusion & Impact:Albumin, interleukin-6 (IL-6), total protein, alanine transaminase, aspartate transaminase, macrophage migration inhibitory factor, and monocyte chemotactic protein-1 measurements were obtained.Results: In rats with liver damage due to arsenic exposure, melatonin administration significantly decreased the levels of IL-6, macrophage migration inhibitory factor, and monocyte chemotactic protein-1 (p<0.001, p=0.02 and p=0.04, respectively).Conclusion: After evaluating liver enzymes and inflammatory markers, this study determined that melatonin exposure improves liver tissue damage caused by arsenic exposure, with the degree of improvement varying based on the levels of arsenic exposure.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Arsenic exposure is increasing in communities due to environmental pollution and industrial development. Arsenic is toxic to organ systems because it causes oxidative stress, enzymatic inhibition, and damage to protein structures. The liver, for example, is an organ that may be damaged by arsenic, and this damage may cause various clinical conditions like hepatic failure or cancer. Melatonin is a hormone that acts like an antioxidant, an anti-inflammatory agent, and a cytoprotective agent. In this study, we aimed to evaluate melatonin's protective effects on livers damaged by arsenic toxicity.Materials and Methods: Twenty-four Sprague-Dawley male rats were classified into three groups: a control group, an arsenic applied group, and an arsenic plus 10 mg/kg melatonin applied group. At the end of the fifteen-day experiment, the rats were sacrificed. Albumin, interleukin-6 (IL-6), total protein, alanine transaminase, aspartate transaminase, macrophage migration inhibitory factor, and monocyte chemotactic protein-1 measurements were obtained.Results: In rats with liver damage due to arsenic exposure, melatonin administration significantly decreased the levels of IL-6, macrophage migration inhibitory factor, and monocyte chemotactic protein-1 (p<0.001, p=0.02 and p=0.04, respectively).Conclusion: After evaluating liver enzymes and inflammatory markers, this study determined that melatonin exposure improves liver tissue damage caused by arsenic exposure, with the degree of improvement varying based on the levels of arsenic exposure.

Özet

Amaç: Sanayideki gelişim ve artan çevre kirliliği sonucunda toplumda arsenik maruziyeti artmaktadır. Arsenik oksidatif hasar, enzim inhibisyonu ve protein yapılara zarar verici etkisiyle organ sistemlerine toksik etki gösterir. Arseniğin ciddi hasar verdiği organlardan biri de karaciğer olup, karaciğer yetmezliğinden kansere kadar farklı düzeylerde tablolara neden olmaktadır. Melatonin antioksidan, anti-inflamatuvar ve sitoprotektif etki gösteren bir hormondur. Bu çalışmada arsenik toksisitesi ile oluşturulan karaciğer hasarında melatoninin koruyucu etkileri araştırılmıştır.Gereç ve Yöntemler: Çalışmada 24 adet Sprague-Dawley türü erkek sıçandan üç grup oluşturulmuştur. Kontrol grubu, arsenik uygulan grup ve arsenik ile 10 mg/kg melatonin verilen grupta, 15 günlük deney sonunda hayvanlar sakrifiye edildikten sonra serumda aspartat transaminaz, alanin transaminaz, total protein, albumin, interlökin-6, makrofaj migrasyon inhibitör faktör, monosit kemotaktik protein-1 ölçümleri yapılmıştır. Bulgular: Arsenik maruziyetinde melatonin uygulamasının interlökin-6, makrofaj migrasyon inhibitör faktör, ve monosit kemotaktik protein-1 düzeylerinde anlamlı bir azalmaya yol açtığı tespit edilmiştir. (sırasıyla p<0,001, p=0,02 ve p=0,04). Sonuç: Karaciğer enzimleri ve inflamatuvar belirteçler üzerinde yapmış olduğumuz bu çalışma sonucunda, arsenik maruziyetine bağlı olarak karaciğerde oluşan doku hasarında melatonin etkisiyle düzelme sağlandığı tespit edilmiştir.

🔖

Cite This Article

BALİ, İ., BİLİR, B., EMİR, S., TURAN, F., YILMAZ, A., GÖKKUŞ, T., AYDIN, M. (2016). Arseniğin sebep olduğu karaciğer hasarında melatoninin karaciğer foksiyonları üzerine etkileri. Ulusal Cerrahi Dergisi, Cilt: 32 - Sayı: 4, 233–237. https://ajindex.com/articles/325327

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Lombi E, Holm PE: Metalloids, soil chemistry and the environ- ment. Adv Exp Med Biol 2010; 679: 33-44. [CrossRef] Wang P, Sun G, Jia Y, Meharg AA, Zhu Y. A review on completing arsenic biogeochemical cycle: microbial volatilization of arsines in environment J Environ Sci 2014; 26: 371-381. [CrossRef] U.S. EPA, Arsenic Treatment Technologies for Soil, Waste and Wa- ter, U.S. EPA/National Service Center for Environmental Publica- tions, Cincinnati, 2002.
  2. P Mangalgiri K, Adak A, Blaney L. Organoarsenicals in poultry litter: Detection, fate, and toxicity. Environ Int 2015; 75: 68-80. [CrossRef] Mandal BK, Suzuki KT. Arsenic round the world: a review. Talanta 2002; 58: 201-235. [CrossRef] Moore K. Treatment of arsenic contaminated groundwater using oxidation and membrane filtration, master of applied science in civil engineering, University of Waterloo, 2005.
  3. Tchounwou PB, Wilson BA, Abdelghani AA, Ishaque AB, Patlolla A. Differential cytotoxicity and gene expression in human liver carcinoma (HepG2) cells exposed to arsenic trioxide and mono- sodium acid methanearsonate (MSMA). Int J Mol Sci 2002; 3: 1117-1132. [CrossRef] Fowler BA, Woods JS, Schiller CM. Ultrastructural and biochemi- cal effects of prolonged oral arsenic exposure on liver mitochon- dria of rats. Environ Health Perspect 1977; 19: 197-204. [CrossRef] Bashir S, Sharma Y, Irshad M, Gupta SD, Dogra TD. Arsenic-in- duced cell death in liver and brain of experimental rats. Basic Clin Pharmacol Toxicol 2006; 98: 38-43. [CrossRef] Bashir S, Sharma Y, Irshad M, Nag TC, Tiwari M, Kabra M, et al. Ar- senic induced apoptosis in rat liver following repeated 60 days exposure. Toxicology 2006; 217: 63-70. [CrossRef] Tosini G, Menaker M. The clock in the mouse retina: melatonin synthesis and photoreceptor degeneration. Brain Res 1998; 789: 221-228. [CrossRef] Conti A, Conconi S, Hertens E, Skwarlo-Sonta K, Markowska M, Maestroni JM. Evidence for melatonin synthesis in Mouse and hu- man bone marrow cells. J Pineal Res 2000; 28: 193-202. [CrossRef] Slominski A, Tobin DJ, Zmijewski MA, Wortsman J, Paus R. Mela- tonin in the skin: synthesis, metabolism and functions. Trends Endocrinol Metab 2008; 19: 17-24. [CrossRef] Champier J, Claustrat B, Besançon R, Eymin C, Killer C, Jouvet A, et al. Evidence for tryptophan hydroxylase and hydroxy-indol- O-methyl-transferase mRNAs in human blood platelets. Life Sci 1997; 60: 2191-2197. [CrossRef] Carrillo-Vico A, Calvo JR, Abreu P, Lardone PJ, García-Mau ri-o S, Reiter RJ, e